Aggressive Infliximab Dosing Shows No Added Benefit in UC
TOPLINE:Aggressive infliximab dosing regimens – intensified induction or accelerated induction – show similar clinical responses and remission rates as the ...
Day: November 19, 2024
FDA Considers New Dupilumab Data for CSU Indication
The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for dupilumab for ...
The Emotional Cost of Nursing School: Depression
Nursing is a competitive field. In 2022, nursing schools rejected more than 78,000 qualified applications, and the students whose applications ...
Early Biologic Therapy Boosts Healing in Crohn’s Disease
TOPLINE:Early initiation of biologic therapy in patients with Crohn’s disease (CD) is associated with higher rates of transmural healing and ...
Telehealth Shows Promise in Reducing Suicide Attempts
TOPLINE:Brief cognitive behavioral therapy (BCBT) even when delivered remotely via video telehealth effectively reduces suicide attempts among high-risk adults. METHODOLOGY:The researchers ...
New Test Offers Quicker Way to Screen for Dementia
SEATTLE — A novel, quick, and low-cost dementia screening test could significantly improve early detection of Alzheimer's disease in primary ...
Treat-to-Target Approach for RA Improves Time to Pregnancy
WASHINGTON — Women with rheumatoid arthritis (RA) experience improved fertility when treated using a treat-to-target (T2T) approach aimed at remission, ...
Which Canadians Have Greater Need?
VANCOUVER, BRITISH COLUMBIA — Amid a lack of consensus on screening men for prostate cancer using the prostate-specific antigen (PSA), ...
Can a Changing World Agree on the WHO Pandemic Treaty?
LISBON, Portugal — “Work together and mobilize our forces” around the Pandemic Treaty, said experts at the 17th European Public ...
Common Heart Failure Drugs Ease Heart Damage During Chemo
Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline ...
New Pill Successfully Lowers Lp(a) Levels
Muvalaplin, a novel oral medication, safely and effectively lowers high levels of lipoprotein(a), or Lp(a), results from the phase 2 ...
